Jin Medical International Ltd.
ZJYL
$0.6407
-$0.0019-0.30%
NASDAQ
| 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 23.50M | 21.81M | 20.13M | 19.97M | 19.82M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 23.50M | 21.81M | 20.13M | 19.97M | 19.82M |
| Cost of Revenue | 13.89M | 13.44M | 13.00M | 12.93M | 12.86M |
| Gross Profit | 9.61M | 8.37M | 7.13M | 7.05M | 6.97M |
| SG&A Expenses | 4.37M | 3.76M | 3.14M | 2.76M | 2.37M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | 107.20K | 123.20K | 139.20K | 159.60K | 180.00K |
| Total Operating Expenses | 19.86M | 18.83M | 17.80M | 17.38M | 16.95M |
| Operating Income | 3.64M | 2.98M | 2.33M | 2.60M | 2.87M |
| Income Before Tax | 4.18M | 3.72M | 3.27M | 3.24M | 3.22M |
| Income Tax Expenses | 763.80K | 606.20K | 448.60K | 396.10K | 343.60K |
| Earnings from Continuing Operations | 3.42 | 3.12 | 2.82 | 2.85 | 2.88 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 256.20K | 173.00K | 89.80K | 44.90K | -- |
| Net Income | 3.68M | 3.29M | 2.91M | 2.89M | 2.88M |
| EBIT | 3.64M | 2.98M | 2.33M | 2.60M | 2.87M |
| EBITDA | 3.88M | 3.22M | 2.56M | 2.82M | 3.09M |
| EPS Basic | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| Normalized Basic EPS | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 |
| EPS Diluted | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 |
| Normalized Diluted EPS | 0.02 | 0.02 | 0.01 | 0.01 | 0.01 |
| Average Basic Shares Outstanding | 625.90M | 624.40M | 622.91M | 601.73M | 580.55M |
| Average Diluted Shares Outstanding | 625.90M | 624.40M | 622.91M | 601.73M | 580.55M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |